Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Mai 2009 06:15 ET | Quelle: MediciNova, Inc.

MediciNova Reports First Quarter 2009 Results

SAN DIEGO, May 15, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
22. April 2009 06:00 ET | Quelle: MediciNova, Inc.

MediciNova Reports Final Data from Phase II MN-221 Emergency Department Clinical Trial (MN-221-CL-006); Hospitalization Rates Decrease 45 Percent With MN-221 Plus Standardized Care in Asthma Patients

SAN DIEGO, April 22, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
31. März 2009 17:10 ET | Quelle: MediciNova, Inc.

MediciNova Reports Fourth Quarter and Full Year 2008 Results

SAN DIEGO, March 31, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
24. März 2009 12:00 ET | Quelle: MediciNova, Inc.

MediciNova Sends Letter to Avigen Board of Directors

SAN DIEGO, March 24, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
19. März 2009 17:06 ET | Quelle: MediciNova, Inc.

MediciNova Sends Letter to Avigen Board of Directors

SAN DIEGO, Calif., March 19, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the...
12. März 2009 09:00 ET | Quelle: MediciNova, Inc.

MediciNova Sends Letter to Avigen Board of Directors

SAN DIEGO, March 12, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
09. Februar 2009 09:00 ET | Quelle: MediciNova, Inc.

MediciNova Reaffirms Proposal to Acquire Avigen, Inc.

SAN DIEGO, Feb. 9, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
12. Januar 2009 06:00 ET | Quelle: MediciNova, Inc.

MediciNova Reports Interim Phase II Data From MN-221 Emergency Department Study

SAN DIEGO, Jan. 12, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
23. Dezember 2008 06:00 ET | Quelle: MediciNova, Inc.

MediciNova Proposes to Acquire Avigen, Inc.

SAN DIEGO, Dec. 23, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
10. November 2008 17:00 ET | Quelle: MediciNova, Inc.

MediciNova Reports Third Quarter 2008 Results

SAN DIEGO, Nov. 10, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...

Vorherige Seite

Nächste Seite